Therefore, the utility of HBME1 has been demonstrated, and it is suggested that the combination of HBME1 and CK19 achieves high sensitivity and specificity in the diagnosis of papillary thyroid carcinoma 16. This evidence concerns the gene KRT19 and thyroid gland papillary carcinoma.